Comparative analysis of the dynamics of healthcare expenditures from country GDP and cash payments of families to medical and pharmaceutical support in Ukraine, CIS countries and ЕU

Authors

DOI:

https://doi.org/10.15587/2519-4852.2020.206569

Keywords:

medical care, health care costs, cash payments made by families for medical and pharmaceutical support, healthcare, pharmaceutical care

Abstract

The aim: conducting a comparative analysis of the dynamics of changes in health expenditures (%) from GDP and cash payments of families for medical and pharmaceutical support from total health expenditures in Ukraine, CIS countries and the EU (members since 2004).

Materials and methods. The data of the WHO Regional Office for Europe and such analysis methods as historical, analytical, comparative, systemic, logical, graphic, mathematical and statistical, etc. were used.

Results. According to the results of the analysis, it was found that the ex­penditures (%) on health care from the GDP of countries and the cash payments (%) made by families on medical and pharmaceutical support from the total ex­penditures on health care in 1990-2014 steadily increasing. At the same time, it was proved that the growth rate (%) of these indicators in Ukraine, the CIS coun­tries and the EU differed both in numerical values and in years of research. The largest and smallest growth values of these indicators were characteristic of Ukraine. In addition, it was internal indicators that were zigzag in their changes, for example, expenditures (%) on health care of the country's GDP in 1995 in­creased to 7.0 % from 3.3 % (1994). It is proved that in Ukraine during 1990-2014 against the background of an increase in expenditures (%) on healthcare from the country's GDP by 2.14 times. Cash (%) payments to the population of total health spending increased 1.9 times. In the CIS countries, over the same period, the above expenses increased 1.7 times, and family cash payments 1.8 times, and in the EU 1.4 times and 1.04 times respectively. Thus, it can be argued that the population of European countries against the background of a systematic increase in health care costs (%) of the country's GDP invariably spends in the form of cash payments for medical and pharmaceutical support no more than 25.0 % of the total health care costs in national health systems.

Conclusions. The presence of unstable dynamics of changes in these macro­economic indicators in Ukraine and the CIS countries compared with similar data that are presented for the EU countries is the result of a lack of a systematic vision of the reform processes of national health systems, as well as a lack of a consistent state policy to provide effective financial support to the population in the process of providing medical and pharmaceutical care

Author Biographies

Oleh Samborskyi, State higher educational institution «Ivano-Frankivsk National Medical University» Halytska str., 2, Ivano-Frankivsk, Ukraine, 76018

PhD, Associate Professor

Department of Organization and Economics of Pharmacy and Drug Technology

Mykola Slobodyanyuk, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Pharmaceutical Marketing and Management

Нanna Panfilova, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Organization and Economics of Pharmacy

References

  1. Darvas Z., Moës, N., Myachenkova, Y., Pichler, D. (2018). The macroeconomic implications of healthcare. Policy Contribution, 11. Available at: https://www.bruegel.org/wp-content/uploads/2018/08/PC-11_2018_cover.pdf
  2. Pakdaman, M., Geravandi, S., Askari, R., Askarishahi, M., Reza Afzali, H. (2019). The effect of macroeconomic indicators on health-care expenditure in Iran. Journal of Education and Health Promotion, 8 (1), 123.
  3. Reeves, A., McKee, M., Basu, S., Stuckler, D. (2014). The political economy of austerity and healthcare: Cross-national analysis of expenditure changes in 27 European nations 1995–2011. Health Policy, 115 (1), 1–8. doi: http://doi.org/10.1016/j.healthpol.2013.11.008
  4. Braithwaite, J., Hibbert, P., Blakely, B., Plumb, J., Hannaford, N., Long, J. C., Marks, D. (2017). Health system frameworks and performance indicators in eight countries: A comparative international analysis. SAGE Open Medicine, 5. doi: http://doi.org/10.1177/2050312116686516
  5. Kutzin, J. (2012). Anything goes on the path to universal coverage? No. Bulletin of the World Health Organization, 90 (11), 867–868. doi: http://doi.org/10.2471/blt.12.113654
  6. Rechel, B. (2019). Funding for public health in Europe in decline? Health Policy, 123 (1), 21–26. doi: http://doi.org/10.1016/j.healthpol.2018.11.014
  7. Loughnane, C., Murphy, A., Mulcahy, M., McInerney, C., Walshe, V. (2018). Have bailouts shifted the burden of paying for healthcare from the state onto individuals? Irish Journal of Medical Science, 188 (1), 5–12. doi: http://doi.org/10.1007/s11845-018-1798-x
  8. Brousselle, A., Benmarhnia, T., Benhadj, L. (2016). What are the benefits and risks of using return on investment to defend public health programs? Preventive Medicine Reports, 3, 135–138. doi: http://doi.org/10.1016/j.pmedr.2015.11.015
  9. Nichols, L. M., Taylor, L. A. (2018). Social Determinants As Public Goods: A New Approach To Financing Key Investments In Healthy Communities. Health Affairs, 37 (8), 1223–1230. doi: http://doi.org/10.1377/hlthaff.2018.0039
  10. Stuckler, D., Reeves, A., Mckee, M. (2017). Social and economic multipliers: What they are and why they are important for health policy in Europe. Scandinavian Journal of Public Health, 45 (18), 17–21. doi: http://doi.org/10.1177/1403494817707124
  11. Lee, J. T., Majeed, A., Millett, C. (2012). User fees in universal health systems. The Lancet, 380 (9854), 1643–1644. doi: http://doi.org/10.1016/s0140-6736(12)61941-2
  12. Towards actionable international comparisons of health system performance: expert revision of the OECD framework and quality indicators. (2015). International Journal for Quality in Health Care, 27 (2), 137–146. doi: http://doi.org/10.1093/intqhc/mzv004
  13. Perić, N., Hofmarcher-Holzhacker, M. M., Simon, J. (2017). Health system performance assessment landscape at the EU level: a structured synthesis of actors and actions. Archives of Public Health, 75 (1). doi: http://doi.org/10.1186/s13690-016-0173-5
  14. Tanza Loudenback The average cost of healthcare in 21 different countries (2019). Вusiness insider Аustralia. Available at: https://www.businessinsider.com.au/cost-of-healthcare-countries-ranked-2019-3
  15. Burbela, A. L. (2017). Derzhavni vytraty na okhoronu zdorovia v Ukraini. Naukovyi visnyk Uzhhorodskoho natsionalnoho universytetu vypusk, 14 (1), 37–40.
  16. Carrera, P. M. (2018). Social Determinants Of Health As Public Goods. Health Affairs, 37 (10), 1710. doi: http://doi.org/10.1377/hlthaff.2018.1115
  17. Sachs, J. D. (2012). Achieving universal health coverage in low-income settings. The Lancet, 380 (9845), 944–947. doi: http://doi.org/10.1016/s0140-6736(12)61149-0
  18. Jowett, M., Brunal, M. P., Flores, G., Cylus, J. (2016). Spending targets for health: no magic number. Geneva: World Health Organization; 2016 (WHO/HIS/HGF/HFWorkingPaper/16.1; Health Financing Working Paper No. 1). Available at: http://apps.who.int/iris/bitstream/10665/250048/1/WHO-HIS-HGFHFWork­ingPaper-16.1-eng.pdf
  19. White, J. (2013). Budget-makers and health care systems. Health Policy, 112 (3), 163–171. doi: http://doi.org/10.1016/j.healthpol.2013.07.024
  20. WHO. European Health Information Gateway. Available at: https://gateway.euro.who.int/en/
  21. Wilson, K. (2016). Innovation and sustainability of European healthcare systems. Bruegel Blog. Аvailable at: https://www.bruegel.org/2016/01/innovation-and-sustainability-of-european-healthcare-systems/?utm_content=buffer1ba87&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer+(bruegel)
  22. Tsurikova, O. V. (2019). A comparative analysis of the dynamics of cash payments of families for medical and pharmaceutical services among the total health spending in Ukraine, Azerbaijan, Armenia, Georgia. Social Pharmacy in Health Care, 5 (4), 31–39. doi: http://doi.org/10.24959/sphhcj.19.171
  23. Tereshchenko, L., Zhirova, I. (2019). Analysis of the dynamics of expenditures on pharmaceutical support of population in Ukraine, Belarus republic and in European Union. ScienceRise: Pharmaceutical Science, 4 (20), 10–14. doi: http://doi.org/10.15587/2519-4852.2019.177193
  24. National strategy for reforming the health care system in Ukraine for the period 2015-2020. Ministry of Health of Ukraine. International Renaissance Founda­tion. 2015. Аvailable at: https://moz.gov.ua/uploads/0/691-strategiya.pdf
  25. McDaid, D., Quaglio, G., Correia de Campos, A., Dario, C., Van Woensel, L., Karapiperis, T., Reeves, A. (2013). Health protection in times of economic crisis: Challenges and opportunities for Europe. Journal of Public Health Policy, 34 (4), 489–501. doi: http://doi.org/10.1057/jphp.2013.35

Downloads

Published

2020-06-30

How to Cite

Samborskyi, O., Slobodyanyuk, M., & Panfilova Н. (2020). Comparative analysis of the dynamics of healthcare expenditures from country GDP and cash payments of families to medical and pharmaceutical support in Ukraine, CIS countries and ЕU. ScienceRise: Pharmaceutical Science, (3 (25), 20–27. https://doi.org/10.15587/2519-4852.2020.206569

Issue

No. 3 (25) (2020)

Section

Pharmaceutical Science

License

Copyright (c) 2020 Oleh Samborskyi, Mykola Slobodyanyuk, Нanna Panfilova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.